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Received November 7, 2011; accepted February 23, 2012AbstractInflammatory pseudotumor of the liver is a rare tumor. It has variable clinical presentations and image findings. It can mimic benign or
malignant hepatic tumors, and may be difficult to diagnose. We present a case in which a hepatic inflammatory pseudotumor was misdiagnosed
as hepatocellular carcinoma because the tumor presented a typical enhancing profile and morphology of hepatocellular carcinoma on computed
tomography, and the patient had liver cirrhosis. However, a thicker tumor capsule than that of typical hepatocellular carcinoma was noted while
reviewing the computed tomography images. A capsule of inflammatory pseudotumor thicker than that of hepatocellular carcinoma has never
been reported in the literature before, and could be an important diagnostic clue to differentiate inflammatory pseudotumor from hepatocellular
carcinoma.
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Keywords: computed tomography; hepatocellular carcinoma; inflammatory pseudotumor; tumor capsule1. Introduction
Inflammatory pseudotumor (IPT) is a benign tumor of un-
certain cause. It is composed of fibrous tissue, lymphocytes,
and plasma cells. The tumor can present in many organs, but
the lungs and liver are the most common sites.1 Various image
findings have been reported, some mimicking those of a ma-
lignant hepatic tumor. We present a case of hepatic IPT with
the typical image findings of hepatocellular carcinoma (HCC)
on computed tomography (CT).
2. Case report
An 85-year-old female with history of chronic hepatitis C
without treatment and type II diabetes mellitus under medical
control visited our outpatient department due to abdominal
fullness. Laboratory data showed elevated serum alanine
transaminase (200 mg/dL) and alpha-fetoprotein (81.6 mg/dL)* Corresponding author. Dr. Chen-Te Chou, Department of Medical Imag-
ing, 135, Nan-Xiao Street, Changhua 500, Taiwan, ROC.
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http://dx.doi.org/10.1016/j.jcma.2013.01.004levels, without elevated serum C-reative protein level,
increased erythrocyte sedimentation rate, or leukocytosis. No
definite body weight loss had been noticed. Physical exami-
nation on admission to our hospital was unremarkable except
for a surgical scar from a previous appendectomy.
Sonography revealed a coarse echogenic background to the
liver and a hypoechoic mass lesion in the right lobe of the liver
measuring 3.5 cm in diameter. Dynamic contrast-enhanced CT
of the abdomen revealed liver cirrhosis with a nodular liver
surface and a well-defined mass lesion, measuring 3.5 cm in
diameter, in segment 5 of the liver, with low density in the
precontrast phase, early inhomogeneous enhancement in the
arterial phase, and contrast medium washout in the venous
phase. A thick, peripheral enhancing tumor capsule measuring
2e3.3 mm in thickness was depicted, more obvious in the
venous phase (Fig. 1). No ascites was noted on the CT
examination.
According to the practice guideline of American Associa-
tion for the Study of Liver Disease, HCC was diagnosed
preoperatively. Because the patient was otherwise well and
was requesting curative treatment, hepatic segmentectomy was
performed.hinese Medical Association. All rights reserved.
Fig. 1. Dynamic abdominal computed tomography revealed a mildly hypodense lesion (arrowed) in segment 5 of the liver (A), measuring 3.5 cm in diameter, with
early enhancement (B,C) and contrast washout in the venous phase (D), and with a hyperdense tumor capsule.
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defined mass with lymphocyte and multiloculated giant
cell infiltration, fibrin deposition, and formation of gran-
ulation tissue (Fig. 2). Foci of caseating granulomatous
inflammation with a necrotic center were surrounded by
epithelioid histiocytes. A thick fibrous capsule measuring
2.5 mm in thickness was also depicted. Special staining withFig. 2. The surgical specimen (A) showed a mass lesion with inner hemorrhage a
photomicrograph (original magnification, 40; H&E stain) revealed lymphoplasma
was inflammatory pseudotumor.periodic acideSchiff and an immunohistochemical study for
tuberculosis failed to demonstrate a fungal or mycobacterial
infection. The final pathologic diagnosis was inflamma-
tory IPT.
After hepatic segmentectomy, the patient was generally
well without complications, except for mild ascites identified
during outpatient department follow-up, for which diureticsnd a peripheral thick fibrous capsule measuring 2.5 mm in thickness. (B) A
cells and multinucleated giant cell infiltration. The final pathologic diagnosis
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follow-up sonography.
3. Discussion
IPT is a benign lesion consisting of proliferating fibrous
tissue infiltrated by inflammatory cells. The tumor can develop
in several organs, such as the brain, spinal cord, larynx, thy-
roid gland, breast, pancreas, gastrointestinal tract, or urinary
bladder, but mostly it develops in the lungs and liver.1 The
pathogenesis of IPT is not clear. Infections (either bacteria or
parasites), autoimmunity, radiation, and chemotherapy have
been considered as possible causes.2 In addition, several dis-
eases have been related to the development of IPT, including
Crohn’s disease, gastrointestinal stromal tumor, congenital
neutropenia, and pregnancy.3 The lesion was first described by
Pack and Baker in 1953.4
Most patients are in their infantile period and between 40 to
70 years of age, and 60% are female.5 The clinical presenta-
tion is also variable, including abdominal mass, abdominal
discomfort, intermittent fever, weight loss, and general mal-
aise. The laboratory findings may reveal an inflammatory
process, with leukocytosis, elevated erythrocyte sedimentation
rate, or increased C-reative protein level. Thus, a clinical
diagnosis of IPT is difficult to achieve due to its variable
presentation. The treatment is also variable. Traditionally,
surgical treatment has been indicated, but recently, spontane-
ous regression of the tumor has been reported after oral non-
steroid anti-inflammatory drugs or antibiotic treatment.6
A radiologic diagnosis of IPT is also difficult because it
shows variable imaging findings and lacks specific findings.
On angiography, the lesion shows hypervascularity, as does
that of HCC.7 On sonography, the lesion usually appears
hypoechoic, but it also can be hyperechoic or lack complex
echogenicity. The inner content of the tumor is usually het-
erogeneous, without definite necrosis or cyst formation.8
The image findings on CT are also variable. On precontrast
CT, the lesion is usually hypodense, and in the delayed phase
the tumor can show a variable enhancement pattern, including
homogeneous enhancement, peripheral enhancement, hetero-
geneous enhancement, or even contrast washout in the delayed
phase.6 The variable delayed-phase enhancement pattern has
been reported to relate to the various components of the
fibrotic part of the tumor.9 Our CT findings of IPT showed the
typical image findings of an HCC enhancing profile, which
includes early enhancement, contrast medium washout in the
venous phase, and a tumor capsule. The patient had liver
cirrhosis, and a preoperative diagnosis of HCC was thus made
according to the results of the imaging.In our case, the tumor capsule seemed thicker than in the
usual presentation of HCC. The tumor capsule is an important
characteristic of HCC, being between 0.3 mm and 1.4 mm
(0.87  0.59 mm) in pathological examination,10 and 98% of
tumor capsules are less than 2 mm thick on an image study.11
However, in our case, the fibrous tumor capsule measured
2e3.3 mm (2.6  0.52 mm), thicker than that seen in typical
HCC. Thus, if a tumor presents typical findings of HCC on
CT, but has a thicker tumor capsule than usual, IPT should be
included in the differential diagnosis, and biopsy should be
performed before operation. However, to the best of our
knowledge, there is no literature discussing the mechanism of
capsular formation in IPT of the liver.
In conclusion, we have presented a case of hepatic IPT that
was misdiagnosed as HCC because it presented the typical
image findings of HCC on CT. We suggest that a thicker tumor
capsule on CT can be an important diagnostic clue to differ-
entiate IPT from HCC.References
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